Cargando…

Effects of Atrial Fibrillation on the Human Ventricle

Atrial fibrillation (AF) and heart failure often coexist, but their interaction is poorly understood. Clinical data indicate that the arrhythmic component of AF may contribute to left ventricular (LV) dysfunction. OBJECTIVE: This study investigates the effects and molecular mechanisms of AF on the h...

Descripción completa

Detalles Bibliográficos
Autores principales: Pabel, Steffen, Knierim, Maria, Stehle, Thea, Alebrand, Felix, Paulus, Michael, Sieme, Marcel, Herwig, Melissa, Barsch, Friedrich, Körtl, Thomas, Pöppl, Arnold, Wenner, Brisca, Ljubojevic-Holzer, Senka, Molina, Cristina E., Dybkova, Nataliya, Camboni, Daniele, Fischer, Thomas H., Sedej, Simon, Scherr, Daniel, Schmid, Christof, Brochhausen, Christoph, Hasenfuß, Gerd, Maier, Lars S., Hamdani, Nazha, Streckfuss-Bömeke, Katrin, Sossalla, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963444/
https://www.ncbi.nlm.nih.gov/pubmed/35193397
http://dx.doi.org/10.1161/CIRCRESAHA.121.319718
_version_ 1784677989895634944
author Pabel, Steffen
Knierim, Maria
Stehle, Thea
Alebrand, Felix
Paulus, Michael
Sieme, Marcel
Herwig, Melissa
Barsch, Friedrich
Körtl, Thomas
Pöppl, Arnold
Wenner, Brisca
Ljubojevic-Holzer, Senka
Molina, Cristina E.
Dybkova, Nataliya
Camboni, Daniele
Fischer, Thomas H.
Sedej, Simon
Scherr, Daniel
Schmid, Christof
Brochhausen, Christoph
Hasenfuß, Gerd
Maier, Lars S.
Hamdani, Nazha
Streckfuss-Bömeke, Katrin
Sossalla, Samuel
author_facet Pabel, Steffen
Knierim, Maria
Stehle, Thea
Alebrand, Felix
Paulus, Michael
Sieme, Marcel
Herwig, Melissa
Barsch, Friedrich
Körtl, Thomas
Pöppl, Arnold
Wenner, Brisca
Ljubojevic-Holzer, Senka
Molina, Cristina E.
Dybkova, Nataliya
Camboni, Daniele
Fischer, Thomas H.
Sedej, Simon
Scherr, Daniel
Schmid, Christof
Brochhausen, Christoph
Hasenfuß, Gerd
Maier, Lars S.
Hamdani, Nazha
Streckfuss-Bömeke, Katrin
Sossalla, Samuel
author_sort Pabel, Steffen
collection PubMed
description Atrial fibrillation (AF) and heart failure often coexist, but their interaction is poorly understood. Clinical data indicate that the arrhythmic component of AF may contribute to left ventricular (LV) dysfunction. OBJECTIVE: This study investigates the effects and molecular mechanisms of AF on the human LV. METHODS AND RESULTS: Ventricular myocardium from patients with aortic stenosis and preserved LV function with sinus rhythm or rate-controlled AF was studied. LV myocardium from patients with sinus rhythm and patients with AF showed no differences in fibrosis. In functional studies, systolic Ca(2+) transient amplitude of LV cardiomyocytes was reduced in patients with AF, while diastolic Ca(2+) levels and Ca(2+) transient kinetics were not statistically different. These results were confirmed in LV cardiomyocytes from nonfailing donors with sinus rhythm or AF. Moreover, normofrequent AF was simulated in vitro using arrhythmic or rhythmic pacing (both at 60 bpm). After 24 hours of AF-simulation, human LV cardiomyocytes from nonfailing donors showed an impaired Ca(2+) transient amplitude. For a standardized investigation of AF-simulation, human iPSC-cardiomyocytes were tested. Seven days of AF-simulation caused reduced systolic Ca(2+) transient amplitude and sarcoplasmic reticulum Ca(2+) load likely because of an increased diastolic sarcoplasmic reticulum Ca(2+) leak. Moreover, cytosolic Na(+) concentration was elevated and action potential duration was prolonged after AF-simulation. We detected an increased late Na(+) current as a potential trigger for the detrimentally altered Ca(2+)/Na(+)-interplay. Mechanistically, reactive oxygen species were higher in the LV of patients with AF. CaMKII (Ca(2+)/calmodulin-dependent protein kinase IIδc) was found to be more oxidized at Met281/282 in the LV of patients with AF leading to an increased CaMKII activity and consequent increased RyR2 phosphorylation. CaMKII inhibition and ROS scavenging ameliorated impaired systolic Ca(2+) handling after AF-simulation. CONCLUSIONS: AF causes distinct functional and molecular remodeling of the human LV. This translational study provides the first mechanistic characterization and the potential negative impact of AF in the absence of tachycardia on the human ventricle.
format Online
Article
Text
id pubmed-8963444
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-89634442022-03-29 Effects of Atrial Fibrillation on the Human Ventricle Pabel, Steffen Knierim, Maria Stehle, Thea Alebrand, Felix Paulus, Michael Sieme, Marcel Herwig, Melissa Barsch, Friedrich Körtl, Thomas Pöppl, Arnold Wenner, Brisca Ljubojevic-Holzer, Senka Molina, Cristina E. Dybkova, Nataliya Camboni, Daniele Fischer, Thomas H. Sedej, Simon Scherr, Daniel Schmid, Christof Brochhausen, Christoph Hasenfuß, Gerd Maier, Lars S. Hamdani, Nazha Streckfuss-Bömeke, Katrin Sossalla, Samuel Circ Res Original Research Atrial fibrillation (AF) and heart failure often coexist, but their interaction is poorly understood. Clinical data indicate that the arrhythmic component of AF may contribute to left ventricular (LV) dysfunction. OBJECTIVE: This study investigates the effects and molecular mechanisms of AF on the human LV. METHODS AND RESULTS: Ventricular myocardium from patients with aortic stenosis and preserved LV function with sinus rhythm or rate-controlled AF was studied. LV myocardium from patients with sinus rhythm and patients with AF showed no differences in fibrosis. In functional studies, systolic Ca(2+) transient amplitude of LV cardiomyocytes was reduced in patients with AF, while diastolic Ca(2+) levels and Ca(2+) transient kinetics were not statistically different. These results were confirmed in LV cardiomyocytes from nonfailing donors with sinus rhythm or AF. Moreover, normofrequent AF was simulated in vitro using arrhythmic or rhythmic pacing (both at 60 bpm). After 24 hours of AF-simulation, human LV cardiomyocytes from nonfailing donors showed an impaired Ca(2+) transient amplitude. For a standardized investigation of AF-simulation, human iPSC-cardiomyocytes were tested. Seven days of AF-simulation caused reduced systolic Ca(2+) transient amplitude and sarcoplasmic reticulum Ca(2+) load likely because of an increased diastolic sarcoplasmic reticulum Ca(2+) leak. Moreover, cytosolic Na(+) concentration was elevated and action potential duration was prolonged after AF-simulation. We detected an increased late Na(+) current as a potential trigger for the detrimentally altered Ca(2+)/Na(+)-interplay. Mechanistically, reactive oxygen species were higher in the LV of patients with AF. CaMKII (Ca(2+)/calmodulin-dependent protein kinase IIδc) was found to be more oxidized at Met281/282 in the LV of patients with AF leading to an increased CaMKII activity and consequent increased RyR2 phosphorylation. CaMKII inhibition and ROS scavenging ameliorated impaired systolic Ca(2+) handling after AF-simulation. CONCLUSIONS: AF causes distinct functional and molecular remodeling of the human LV. This translational study provides the first mechanistic characterization and the potential negative impact of AF in the absence of tachycardia on the human ventricle. Lippincott Williams & Wilkins 2022-02-23 2022-04-01 /pmc/articles/PMC8963444/ /pubmed/35193397 http://dx.doi.org/10.1161/CIRCRESAHA.121.319718 Text en © 2022 The Authors. https://creativecommons.org/licenses/by-nc-nd/4.0/Circulation Research is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Original Research
Pabel, Steffen
Knierim, Maria
Stehle, Thea
Alebrand, Felix
Paulus, Michael
Sieme, Marcel
Herwig, Melissa
Barsch, Friedrich
Körtl, Thomas
Pöppl, Arnold
Wenner, Brisca
Ljubojevic-Holzer, Senka
Molina, Cristina E.
Dybkova, Nataliya
Camboni, Daniele
Fischer, Thomas H.
Sedej, Simon
Scherr, Daniel
Schmid, Christof
Brochhausen, Christoph
Hasenfuß, Gerd
Maier, Lars S.
Hamdani, Nazha
Streckfuss-Bömeke, Katrin
Sossalla, Samuel
Effects of Atrial Fibrillation on the Human Ventricle
title Effects of Atrial Fibrillation on the Human Ventricle
title_full Effects of Atrial Fibrillation on the Human Ventricle
title_fullStr Effects of Atrial Fibrillation on the Human Ventricle
title_full_unstemmed Effects of Atrial Fibrillation on the Human Ventricle
title_short Effects of Atrial Fibrillation on the Human Ventricle
title_sort effects of atrial fibrillation on the human ventricle
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963444/
https://www.ncbi.nlm.nih.gov/pubmed/35193397
http://dx.doi.org/10.1161/CIRCRESAHA.121.319718
work_keys_str_mv AT pabelsteffen effectsofatrialfibrillationonthehumanventricle
AT knierimmaria effectsofatrialfibrillationonthehumanventricle
AT stehlethea effectsofatrialfibrillationonthehumanventricle
AT alebrandfelix effectsofatrialfibrillationonthehumanventricle
AT paulusmichael effectsofatrialfibrillationonthehumanventricle
AT siememarcel effectsofatrialfibrillationonthehumanventricle
AT herwigmelissa effectsofatrialfibrillationonthehumanventricle
AT barschfriedrich effectsofatrialfibrillationonthehumanventricle
AT kortlthomas effectsofatrialfibrillationonthehumanventricle
AT popplarnold effectsofatrialfibrillationonthehumanventricle
AT wennerbrisca effectsofatrialfibrillationonthehumanventricle
AT ljubojevicholzersenka effectsofatrialfibrillationonthehumanventricle
AT molinacristinae effectsofatrialfibrillationonthehumanventricle
AT dybkovanataliya effectsofatrialfibrillationonthehumanventricle
AT cambonidaniele effectsofatrialfibrillationonthehumanventricle
AT fischerthomash effectsofatrialfibrillationonthehumanventricle
AT sedejsimon effectsofatrialfibrillationonthehumanventricle
AT scherrdaniel effectsofatrialfibrillationonthehumanventricle
AT schmidchristof effectsofatrialfibrillationonthehumanventricle
AT brochhausenchristoph effectsofatrialfibrillationonthehumanventricle
AT hasenfußgerd effectsofatrialfibrillationonthehumanventricle
AT maierlarss effectsofatrialfibrillationonthehumanventricle
AT hamdaninazha effectsofatrialfibrillationonthehumanventricle
AT streckfussbomekekatrin effectsofatrialfibrillationonthehumanventricle
AT sossallasamuel effectsofatrialfibrillationonthehumanventricle